- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 12, 2025 | 30.98M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $2.67M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $1.39M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $11.81M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $9.93M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $18.47M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $14.54M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $33.28M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $30.87M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 30.81M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $684K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $1.87M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $27.26M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $31.43M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.19 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.19 |
| Net Income | Q1 2025 · Mar 31, 2024 | $5.85M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $5.8M |